The BioPharm Insight databank includes information from over 11,000 investigational drug programs, 15,000 launched products and 2,000 global biotechnology and pharmaceutical firms.
"Biotechnology and pharmaceutical companies make up more than 25% of our client base. The information that Infinata offers through BioPharm Insight will be indispensable for our clients in these areas and will provide data that both our Specialists and clients are unable to find through other resources," said Nerac's President Kevin Bouley.
With access to the BioPharm Insight resource, Nerac's Information Specialists will be able to search for drug development activities that include recently approved drugs, drugs with expired patents, prescription and wholesale data, investigational drug programs, clinical trial results, drug family information and thousands of drugs and compounds available for in-licensing through Drug Marketplace
"As an information provider for scientists and engineers, Nerac is a perfect fit for the BioPharm Insight resource," said Sean Power, Executive Vice President of Infinata. "The information we gather provides critical intelligence for business development groups at biotechnology and pharmaceutical companies looking to keep a keen eye on competitors, new licensing opportunities and the projected fate of their own products."
About Nerac
For nearly four decades, Nerac has been delivering customized technical information to companies that conduct research and development in all industries. With a powerful search engine and access to nearly every journal article and conference paper published in the last 37 years, Nerac's Information Specialists bring human intelligence to the search process and work one-on-one with clients to retrieve information from international engineering, scientific, patent and business resources. Based in Tolland, Connecticut, Nerac provides information services globally via the web at www.nerac.com.
CONTACT: Suzi Craig-Edwards, Nerac.com, 860-872-7000
About Infinata/BioPharm Insight
BioPharm Insight
CONTACT: Sean Power, Infinata, biopharminsight.com, 781-949-0067